Cargando…
Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932698/ https://www.ncbi.nlm.nih.gov/pubmed/27377374 http://dx.doi.org/10.1186/s12985-016-0575-6 |
_version_ | 1782441110463840256 |
---|---|
author | Costa, Galileu Barbosa Augusto, Lídia Teodoro Santos Leite, Juliana Almeida Ferreira, Paulo César Peregrino Bonjardim, Cláudio Antônio Abrahão, Jônatas Santos Kroon, Erna Geessien Moreno, Elizabeth Castro Trindade, Giliane de Souza |
author_facet | Costa, Galileu Barbosa Augusto, Lídia Teodoro Santos Leite, Juliana Almeida Ferreira, Paulo César Peregrino Bonjardim, Cláudio Antônio Abrahão, Jônatas Santos Kroon, Erna Geessien Moreno, Elizabeth Castro Trindade, Giliane de Souza |
author_sort | Costa, Galileu Barbosa |
collection | PubMed |
description | BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV. METHODS: A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression. RESULTS: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were independently associated with anti-OPV neutralizing antibodies. CONCLUSIONS: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection. |
format | Online Article Text |
id | pubmed-4932698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49326982016-07-06 Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV Costa, Galileu Barbosa Augusto, Lídia Teodoro Santos Leite, Juliana Almeida Ferreira, Paulo César Peregrino Bonjardim, Cláudio Antônio Abrahão, Jônatas Santos Kroon, Erna Geessien Moreno, Elizabeth Castro Trindade, Giliane de Souza Virol J Research BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV. METHODS: A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression. RESULTS: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were independently associated with anti-OPV neutralizing antibodies. CONCLUSIONS: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection. BioMed Central 2016-07-04 /pmc/articles/PMC4932698/ /pubmed/27377374 http://dx.doi.org/10.1186/s12985-016-0575-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Costa, Galileu Barbosa Augusto, Lídia Teodoro Santos Leite, Juliana Almeida Ferreira, Paulo César Peregrino Bonjardim, Cláudio Antônio Abrahão, Jônatas Santos Kroon, Erna Geessien Moreno, Elizabeth Castro Trindade, Giliane de Souza Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV |
title | Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV |
title_full | Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV |
title_fullStr | Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV |
title_full_unstemmed | Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV |
title_short | Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV |
title_sort | seroprevalence of orthopoxvirus in rural brazil: insights into anti-opv immunity status and its implications for emergent zoonotic opv |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932698/ https://www.ncbi.nlm.nih.gov/pubmed/27377374 http://dx.doi.org/10.1186/s12985-016-0575-6 |
work_keys_str_mv | AT costagalileubarbosa seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT augustolidiateodorosantos seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT leitejulianaalmeida seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT ferreirapaulocesarperegrino seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT bonjardimclaudioantonio seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT abrahaojonatassantos seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT kroonernageessien seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT morenoelizabethcastro seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv AT trindadegilianedesouza seroprevalenceoforthopoxvirusinruralbrazilinsightsintoantiopvimmunitystatusanditsimplicationsforemergentzoonoticopv |